期刊文献+

老年2型糖尿病周围神经病变患者治疗策略的研究 被引量:1

Study on the treatment strategy of elderly patients with type 2 diabetes mellitus diabetic peripheral neuropathy
下载PDF
导出
摘要 目的:探讨药物联用对老年2型糖尿病周围神经病变的治疗效果。方法:收治老年2型糖尿病并发周围神经病变患者196例,随机分成4组,比较治疗效果。结果:1治疗后,4组患者的神经病变主觉症状评分均显著改善(P<0.05),且硫辛酸+前列地尔组与其他3组比较,差异有统计学意义(P<0.05)。2治疗后,依帕司他+硫辛酸+前列地尔组运动传导速度、感觉传导速度与其他3组比较,差异有统计学意义(P<0.05)。结论:3种药物联用治疗老年2型糖尿病周围神经病变的疗效优于两两药物联用。 Objective:To investigate the therapeutic effect of drug combination on peripheral neuropathy in elderly patients withtype 2 diabetes mellitus.Methods:196 elderly patients with type 2 diabetes mellitus complicated with peripheral neuropathy wereselected.They were randomly divided into four groups.We compared the treatment effects.Results:①After treatment,the scores ofmain symptoms of neuropathy in the four groups were significantly improved(P<0.05),and there were significant differencesbetween lipoic acid plus alprostadil group with the other three groups(P<0.05). ② After treatment,there were significantdifferences between epalrestat plus lipoic acid plus alprostadil group with other three groups in motor conduction velocity andsensory conduction velocity(P<0.05).Conclusion:Combination of the three drugs in the treatment of elderly patients with type 2diabetes mellitus was superior to the efficacy of two drugs combination.
作者 常杰 Chang Jie(Binzhou Medical University 264003)
机构地区 滨州医学院
出处 《中国社区医师》 2016年第35期40-42,共3页 Chinese Community Doctors
关键词 2型糖尿病周围神经病变 前列地尔 依帕司他 硫辛酸 Type 2 diabetic peripheral neuropathy Alprostadil Epalrestat Lipoic acid
  • 相关文献

参考文献7

二级参考文献53

  • 1蒋东艳.甲钴胺与前列地尔联合治疗糖尿病感觉神经病变[J].中国基层医药,2005,12(9):1263-1263. 被引量:9
  • 2孟俊华,李晓英,邵丽敏,王磊,郝建玲,王红.前列地尔治疗糖尿病周围神经病变的疗效和安全性[J].药物不良反应杂志,2006,8(1):22-23. 被引量:10
  • 3钟历勇.糖尿病神经病变诊疗原则[J].中国疼痛医学杂志,2006,12(4):196-196. 被引量:26
  • 4姜良花,王忠富,杨同艳.Lipo PGE_1治疗DPN疗效观察[J].实用糖尿病杂志,2007,3(1):31-32. 被引量:17
  • 5高妍.重视糖尿病周围神经病变的抗氧化治疗.国际糖尿病,2009,1(20):16-17.
  • 6Hamada Y,Nakamura J,Naruse K,et al.Epalrestat,an aldose reductase inhibitor,reduces the levels of Nepsilon-(earboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients(J).Diabetes Care,2000;23(10):1539-44.
  • 7Kashyap AS, Anand KP, Kashyap S, et al. Peripheral neuropathy [J]. Lancet,2004,364(9446) :1664 - 1665.
  • 8Okuda Y, Mizutani T, Ikegami, et al. Hemodynamic effeets of cilostazol on peripheral artery in patients with diabetic neuropathy [ J ]. Arzneimittelforschung, ! 992,42 (4) : 540 - 542.
  • 9Schror K, Hohlfeld T. Mechanisms of anti-ischemic action of prostaglan-din El in peripheral arterial occlusive disease [ J]. Vasa,2004;33(3 ):119-24.
  • 10高妍.重视糖尿病周围神经病变的抗氧化治疗.国际糖尿病,2009,20(1):16-17.

共引文献133

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部